This randomized , double blind , double-dummy , @-period crossover trial compared single doses of corifollitropin alfa @ g ( therapeutic dose ) , corifollitropin alfa @ g ( supratherapeutic dose ) , and moxifloxacin @ mg ( positive control ) with placebo .